U.S. Markets close in 1 hr 32 mins
  • S&P 500

    4,478.86
    +7.49 (+0.17%)
     
  • Dow 30

    35,215.92
    -78.84 (-0.22%)
     
  • Nasdaq

    14,988.12
    +90.78 (+0.61%)
     
  • Russell 2000

    2,266.54
    +0.89 (+0.04%)
     
  • Gold

    1,767.10
    -1.20 (-0.07%)
     
  • EUR/USD

    1.1620
    +0.0019 (+0.1627%)
     
  • 10-Yr Bond

    1.5830
    +0.0640 (+4.21%)
     
  • Vix

    16.43
    +0.13 (+0.80%)
     
  • GBP/USD

    1.3738
    +0.0061 (+0.4451%)
     
  • USD/JPY

    114.2080
    +0.5310 (+0.4671%)
     
  • BTC-USD

    61,946.04
    +1,009.13 (+1.66%)
     
  • CMC Crypto 200

    1,441.91
    -9.72 (-0.67%)
     
  • FTSE 100

    7,203.83
    -30.20 (-0.42%)
     
  • Nikkei 225

    29,025.46
    +474.56 (+1.66%)
     

Nu Skin (NUS) Queued for Q2 Earnings: Key Things to Note

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Nu Skin Enterprises, Inc. NUS is likely to register growth in the top and the bottom line when it reports second-quarter 2021 numbers on Aug 4.

The Zacks Consensus Estimate for quarterly earnings, which has remained unchanged at $1.06 per share in the past 30 days, suggests an improvement of 30.9% from the year-ago quarter’s reported figure. This cosmetic, personal care and wellness products provider has a trailing four-quarter earnings surprise of 18.8%, on average. In the last reported quarter, the company delivered an earnings surprise of 26.4%.

The Zacks Consensus Estimate for second-quarter revenues is pegged at $702.6 million, which suggests an increase of 14.7% from the figure reported in the prior-year quarter.

Nu Skin Enterprises, Inc. Price and EPS Surprise

Nu Skin Enterprises, Inc. Price and EPS Surprise
Nu Skin Enterprises, Inc. Price and EPS Surprise

Nu Skin Enterprises, Inc. price-eps-surprise | Nu Skin Enterprises, Inc. Quote

Things To Note

Nu Skin is benefiting from efforts to strengthen sales leader and expand the customer base. Management is making significant investments in the digital platform to boost online sales amid the pandemic. The company’s focus on innovation and effective product launches have also been driving growth. We believe that such upsides are likely to have benefited the company’s performance in the quarter under review.

For the second quarter of 2021, Nu Skin projects revenues of $680-$705 million including favorable currency impacts of nearly 5%. The projection suggests year-over-year improvement of 11-15%. Quarterly earnings per share are anticipated between 97 cents and $1.07, indicating 20-32% growth from the year-ago quarter’s level.

That being said, Nu Skin’s gross margin has been contracting year over year for a while due to increased freight costs. Escalated selling expenses as well as general and administrative costs are also a threat to its performance.

What the Zacks Model Unveils

Our proven model doesn’t conclusively predict an earnings beat for Nu Skin this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Nu Skin currently carries a Zacks Rank #4 (Sell) and has an Earnings ESP of +0.94%.

Some Stocks With Favorable Combinations

Here are some companies that you may want to consider as our model shows that these have the right combination of elements to post an earnings beat in the to-be-reported quarter.

Medifast MED currently has an Earnings ESP of +7.27% and carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.

Tyson Foods, Inc. TSN currently has an Earnings ESP of +11.17% and a Zacks Rank of 3.

B&G Foods, Inc. BGS currently has an Earnings ESP of +6.82% and a Zacks Rank of 3.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Tyson Foods, Inc. (TSN) : Free Stock Analysis Report

B&G Foods, Inc. (BGS) : Free Stock Analysis Report

Nu Skin Enterprises, Inc. (NUS) : Free Stock Analysis Report

MEDIFAST INC (MED) : Free Stock Analysis Report

To read this article on Zacks.com click here.